Bone disease after kidney transplantation

Stehman-Breen, 2000, Risk factors for hip fracture among patients with end-stage renal disease, Kidney Int, 58, 2200, 10.1111/j.1523-1755.2000.00394.x Alem, 2000, Increased risk of hip fracture among patients with end-stage renal disease, Kidney Int, 58, 396, 10.1046/j.1523-1755.2000.00178.x Ball, 2002, Risk of hip fracture among dialysis and renal transplant recipients, JAMA, 288, 3014, 10.1001/jama.288.23.3014 Elmstedt, 1981, Skeletal complications following renal transplantation, Acta Orthop Scand, 52, 279, 10.3109/17453678109050104 Davidson, 1985, Osteonecrosis and fractures following renal transplantation, Clin Radiol, 36, 27, 10.1016/S0009-9260(85)80012-X Ramsey-Goldman, 1999, Increased risk of fracture in patients receiving solid organ transplants, J Bone Miner Res, 14, 456, 10.1359/jbmr.1999.14.3.456 Arlen, 2001, Treatment of established bone loss after renal transplantation with etidronate, Transplantation, 71, 669, 10.1097/00007890-200103150-00017 O’Shaughnessy, 2002, Risk factors for fractures in kidney transplantation, Transplantation, 74, 362, 10.1097/00007890-200208150-00012 Durieux, 2002, Bone mineral density and fracture prevalence in long-term kidney graft recipients, Transplantation, 74, 496, 10.1097/00007890-200208270-00011 Grotz, 1994, Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients, Transplantation, 58, 912, 10.1097/00007890-199410270-00009 Parker, 1999, Cross-sectional analysis of renal transplantation osteoporosis, J Bone Miner Res, 14, 1943, 10.1359/jbmr.1999.14.11.1943 Patel, 2001, Prevalence and causes of low bone density and fractures in kidney transplant patients, J Bone Miner Res, 16, 1863, 10.1359/jbmr.2001.16.10.1863 D’Angelo, 2000, Parathyroid hormone and bone metabolism in kidney-transplanted patients, Clin Nephrol, 53, 19 Nam, 2000, Prevalence and risk factors for vertebral fractures in renal transplants, Transplant Proc, 32, 1877, 10.1016/S0041-1345(00)01472-X Chiu, 1998, Analysis of fracture prevalence in kidney-pancreas allograft recipients, J Am Soc Nephrol, 9, 677, 10.1681/ASN.V94677 Nisbeth, 1999, Increased fracture rate in diabetes mellitus and females after renal transplantation, Transplantation, 67, 1218, 10.1097/00007890-199905150-00004 Abbott, 2001, Hospitalizations for fractures after renal transplantation in the United States, Ann Epidemiol, 11, 450, 10.1016/S1047-2797(01)00226-5 Kwan, 1992, Changes in total body bone mineral content and regional bone mineral density in renal patients following renal transplantation, Miner Electrolyte Metab, 18, 166 Feber, 1994, Bone mineral density after renal transplantation in children, J Pediatr, 6, 870, 10.1016/S0022-3476(05)82001-3 McIntyre, 1995, Long-term bone loss after renal transplantation, Clin Transplant, 9, 20 Torres, 1996, Influence of vitamin D receptor genotype on bone mass changes after renal transplantation, Kidney Int, 50, 1726, 10.1038/ki.1996.492 Yun, 1996, Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation, Transplant Proc, 28, 1561 Kim, 1998, Effect of deflazacort on bone mineral density in renal transplant recipients, Transplant Proc, 30, 3041, 10.1016/S0041-1345(98)00921-X Lippuner, 1998, Effects of deflazacort versus prednisone on bone mass, body composition and lipid profile, J Clin Endocrinol Metab, 83, 3795, 10.1210/jc.83.11.3795 Smets, 1998, Pattern of bone loss after simultaneous pancreas-kidney transplantation, Transplant Proc, 30, 326, 10.1016/S0041-1345(97)01290-6 Isiklar, 1998, Changes in bone mineral density after renal transplantation, Transplant Proc, 30 Moreno, 1999, Bone mineral density after renal transplantation, Transplant Proc, 31, 2322, 10.1016/S0041-1345(99)00360-7 Fan, 2000, Pamidronate therapy as prevention of bone loss following renal transplantation, Kidney Int, 57, 684, 10.1046/j.1523-1755.2000.00890.x Nam, 2000, Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation, Transplant Proc, 32, 1876, 10.1016/S0041-1345(00)01898-4 Kokado, 2000, Factors influencing vertebral bone density after renal transplantation, Transpl Int, 13, S431, 10.1007/s001470050377 Goffin, 2002, Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation, Transpl Int, 15, 73, 10.1111/j.1432-2277.2002.tb00133.x Julian, 1991, Rapid loss of vertebral mineral density after renal transplantation, N Engl J Med, 325, 544, 10.1056/NEJM199108223250804 Horber, 1994, Changes in bone mass early after kidney transplantation, J Bone Miner Res, 9, 1, 10.1002/jbmr.5650090102 Almond, 1994, Loss of regional bone mineral density in the first 12 months following renal transplantation, Nephron, 66, 52, 10.1159/000187765 Grotz, 2001, Effect of ibandronate on bone loss and renal function after kidney transplantation, J Am Soc Nephrol, 12, 1530, 10.1681/ASN.V1271530 Grotz, 1995, Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation, Transplantation, 59, 982, 10.1097/00007890-199504150-00010 Ugur, 2001, Osteoporosis after renal transplantation, Transplantation, 71, 645, 10.1097/00007890-200103150-00011 Nowacka-Cieciura, 2002, Steroid withdrawal after renal transplantation-risks and benefits, Transplant Proc, 34, 560, 10.1016/S0041-1345(01)02846-9 Aroldi, 1997, Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients, Transplantation, 63, 380, 10.1097/00007890-199702150-00009 Bagni, 1994, Continuing loss of vertebral mineral density in renal transplant recipients, Eur J Nucl Med, 21, 108, 10.1007/BF00175756 Hurst, 1998, Stabilization of bone mass after renal transplant with preemptive care, Transplant Proc, 30, 1327, 10.1016/S0041-1345(98)00262-0 Yazawa, 1998, Positive effects of kidney transplantation on bone mass, Transplant Proc, 30, 3031, 10.1016/S0041-1345(98)00917-8 Kim, 1998, Bone mineral density after renal transplantation, Transplant Proc, 30, 3029, 10.1016/S0041-1345(98)00916-6 Cueto-Manzano, 2000, Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation, Am J Kidney Dis, 35, 227, 10.1016/S0272-6386(00)70331-3 Grotz, 1998, Treatment of osteopenia and osteoporosis after kidney transplantation, Transplantation, 66, 1004, 10.1097/00007890-199810270-00007 Cruz, 2001, Parameters of high bone-turnover predict bone loss in renal transplant patients, Transplantation, 72, 83, 10.1097/00007890-200107150-00017 Brandenburg, 2002, Development of lumbar bone mineral density in the late course after kidney transplantation, Am J Kidney Dis, 40, 1066, 10.1053/ajkd.2002.36345 Smets, 1998, Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation, Nephrol Dial Transplant, 13, 1250, 10.1093/ndt/13.5.1250 Velasquez-Forero, 1996, Adynamic bone lesion in renal transplant recipients with normal renal function, Nephrol Dial Transplant, 11, 58, 10.1093/ndt/11.supp3.58 Braun, 1999, The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine, Transplant Proc, 31, 1366, 10.1016/S0041-1345(98)02031-4 Carlini, 2000, Bone disease in patients with long-term renal transplantation and normal renal function, Am J Kidney Dis, 36, 160, 10.1053/ajkd.2000.8289 Heaf, 2000, Bone loss after renal transplantation, Clin Transplant, 14, 457, 10.1034/j.1399-0012.2000.140503.x Ellis, 2000, Risk factors for bone mineral density loss in pediatric renal transplant patients, Pediatr Transplant, 4, 146, 10.1034/j.1399-3046.2000.00106.x Cayco, 2000, Posttransplant bone disease, Transplantation, 70, 1722, 10.1097/00007890-200012270-00011 Kovac, 2001, Bone mineral density in kidney transplant recipients, Transplant Proc, 33, 3668, 10.1016/S0041-1345(01)02581-7 Pichette, 1996, Long-term bone loss in kidney transplant recipients, Am J Kidney Dis, 28, 105, 10.1016/S0272-6386(96)90138-9 Wolpaw, 1994, Factors influencing vertebral bone density after renal transplantation, Transplantation, 58, 1186, 10.1097/00007890-199412270-00008 Boiskin, 1989, Serum osteocalcin and bone mineral metabolism following successful renal transplantation, Clin Nephrol, 31, 316 Schmidt, 1989, Osteocalcin serum levels in patients following renal transplantation, Klin Wochenschr, 67, 297, 10.1007/BF01892898 Saha, 1994, Sequential changes in vitamin D and calcium metabolism after successful renal transplantation, Scand J Urol Nephrol, 28, 21, 10.3109/00365599409180465 Withold, 1995, Monitoring of bone resorption after renal transplantation by measuring the urinary excretion of pyridinium cross-links, Eur J Clin Chem Clin Biochem, 33, 15 Bonnin, 1997, Changes in serum osteocalcin levels in the follow-up of kidney transplantation, Ann Clin Biochem, 34, 651, 10.1177/000456329703400609 Barbarykin, 1999, Disorders of calcium metabolism at various times after renal transplantation, Ann Transplant, 4, 46 Kusec, 2000, Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation, Croat Med J, 41, 396 Westeel, 2000, Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation, Kidney Int, 58, 1788, 10.1046/j.1523-1755.2000.00341.x Cundy, 1987, Rapid suppression of plasma alkaline phosphatase activity after renal transplantation in patients with osteodystrophy, Clin Chim Acta, 164, 285, 10.1016/0009-8981(87)90303-2 van Straalen, 1991, Bone-alkaline phosphatase as indicator of bone formation, Clin Chim Acta, 201, 27, 10.1016/0009-8981(91)90021-4 Withold, 1997, Serum bone alkaline phosphatase is superior to plasma levels of bone matrix proteins for assessment of bone metabolism in patients receiving renal transplants, Clin Chim Acta, 261, 105, 10.1016/S0009-8981(97)06519-4 Withold, 1995, Comparison between serum levels of bone alkaline phosphatase and the carboxy-terminal propeptide of type I procollagen as markers of bone formation in patients following renal transplantation, Clin Chim Acta, 239, 143, 10.1016/0009-8981(95)06109-Q Epstein, 1985, Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation, J Clin Endocrinol Metab, 60, 1253, 10.1210/jcem-60-6-1253 Reusz, 2000, Bone metabolism and mineral density following renal transplantation, Arch Dis Child, 83, 146, 10.1136/adc.83.2.146 Pietschmann, 1991, Bone metabolism in patients with functioning kidney grafts, Nephron, 59, 533, 10.1159/000186639 Amado, 1989, Hyperparathyroidism is responsible for the increased levels of osteocalcin in patients with normally functioning kidney grafts, Nephron, 52, 209, 10.1159/000185644 Dumoulin, 1997, No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients, Am J Kidney Dis, 29, 746, 10.1016/S0272-6386(97)90129-3 Giannini, 2001, Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation, Clin Nephrol, 56, 353 Briner, 1995, Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation, Transplantation, 59, 1393, 10.1097/00007890-199505270-00006 Carlini, 1998, What are the bone lesions in patients with more than four years of a functioning renal transplant, Nephrol Dial Transplant, 13, 103, 10.1093/ndt/13.suppl_3.103 Cueto-Manzano, 1999, Bone loss in long-term renal transplantation, Kidney Int, 55, 2021, 10.1046/j.1523-1755.1999.00445.x Sanchez, 1998, Bone disease in children and adolescents undergoing successful renal transplantation, Kidney Int, 53, 1358, 10.1046/j.1523-1755.1998.00866.x Weisinger, 1999, Bone disease after renal transplantation, Transplant Proc, 31, 3033, 10.1016/S0041-1345(99)00658-2 Monier-Faugere, 2000, High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation, J Am Soc Nephrol, 11, 1093, 10.1681/ASN.V1161093 Parker, 2002, Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women, Am J Kidney Dis, 40, 385, 10.1053/ajkd.2002.34535 Rubin, 2002, Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: A re-examination of the evidence, J Clin Endocrinol Metab, 87, 4033, 10.1210/jc.2002-012101 Epstein, 1996, Post-transplantation bone disease, J Bone Miner Res, 11, 1, 10.1002/jbmr.5650110102 Stewart, 1989, Cyclosporines, Calcif Tissue Int, 45, 222, 10.1007/BF02556041 Stewart, 1989, Interaction of cyclosporine A and calcitonin on bone resorption in vitro, Horm Metab Res, 21, 194, 10.1055/s-2007-1009189 Bowman, 1997, The role of testosterone in cyclosporine-induced osteopenia, J Bone Miner Res, 12, 607, 10.1359/jbmr.1997.12.4.607 Epstein, 2001, Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat, Calcif Tissue Int, 68, 240, 10.1007/s002230001167 Awumey, 1999, Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast, Biochem Biophys Res Commun, 254, 248, 10.1006/bbrc.1998.9785 Buchinsky, 1996, T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia, Endocrinology, 137, 2278, 10.1210/en.137.6.2278 Ponticelli, 2001, Osteoporosis after organ transplantation, Lancet, 357, 1623, 10.1016/S0140-6736(00)04765-6 Grotz, 1994, Missing impact of cyclosporine on osteoporosis in renal transplant recipients, Transplant Proc, 26, 2652 Monegal, 2001, Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A, Calcif Tissue Int, 68, 83, 10.1007/BF02678145 Sambrook, 1999, Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation, Calcif Tissue Int, 65, 341, 10.1007/s002239900709 Lippuner, 1996, Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids, Miner Electrolyte Metab, 22, 207 Meys, 1993, Bone loss after cardiac transplantation, Osteoporos Int, 3, 322, 10.1007/BF01637318 Garcia-Delgado, 1997, Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation, Calcif Tissue Int, 60, 155, 10.1007/s002239900206 Josephson, 2000, Calcium and calcitriol prophylaxis against post-transplant bone loss, J Am Soc Nephrol, 11, 720A Giannini, 2001, Alendronate prevents further bone loss in renal transplant recipients, J Bone Miner Res, 16, 2111, 10.1359/jbmr.2001.16.11.2111 Kovac, 2001, Prevention of bone loss in kidney graft recipients, Transplant Proc, 33, 1144, 10.1016/S0041-1345(00)02464-7 Haas, 2003, Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation, Kidney Int, 63, 1130, 10.1046/j.1523-1755.2003.00816.x Markowitz, 2001, Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate, J Am Soc Nephrol, 12, 1164, 10.1681/ASN.V1261164